News|Videos|July 11, 2024
Choosing Between Moderate Therapies for Mild/Moderate Multiple Sclerosis
Key opinion leaders share their approach to treatment sequencing for patients with multiple sclerosis (MS), taking into account comorbidities such as cardiovascular diseases, risk of infection, liver damage, and cancer as well as considering factors like planned pregnancy or advanced age.
Advertisement
- How do you choose between different therapies for moderate MS in the context of other conditions?
- Patients with comorbidities (eg, cardiovascular diseases, risk of infection, liver damage, cancer)
- Patients considering pregnancy in the near future
- Patients who have late onset MS or are older
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
2
EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits
3
Current Challenges and New Opportunities Ahead for Women in Neurology
4
Evolving Responsibilities of Vice Chairs in Neurology Leadership: Mud Alvi, MD
5